Preliminary evidence of health care provider support for naloxone prescription as overdose fatality prevention strategy in New York City
- PMID: 12791804
- PMCID: PMC3456271
- DOI: 10.1093/jurban/jtg031
Preliminary evidence of health care provider support for naloxone prescription as overdose fatality prevention strategy in New York City
Abstract
Preliminary research suggests that naloxone (Narcan), a short-acting opiate antagonist, could be provided by prescription or distribution to heroin users to reduce the likelihood of fatality from overdose. We conducted a random postal survey of 1100 prescription-authorized health care providers in New York City to determine willingness to prescribe naloxone to patients at risk of an opiate overdose. Among 363 nurse practitioners, physicians, and physician assistants responding, 33.4% would consider prescribing naloxone, and 29.4% were unsure. This preliminary study suggests that a substantial number of New York City health care providers would prescribe naloxone for opiate overdose prevention.
Similar articles
-
Evaluation of a naloxone distribution and administration program in New York City.Subst Use Misuse. 2008;43(7):858-70. doi: 10.1080/10826080701801261. Subst Use Misuse. 2008. PMID: 18570021
-
Physicians' knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose: challenges and opportunities.J Urban Health. 2007 Jan;84(1):126-36. doi: 10.1007/s11524-006-9120-z. J Urban Health. 2007. PMID: 17146712 Free PMC article.
-
Barriers to medical provider support for prescription naloxone as overdose antidote for lay responders.Subst Use Misuse. 2013 May;48(7):558-67. doi: 10.3109/10826084.2013.787099. Subst Use Misuse. 2013. PMID: 23647168
-
The distribution of naloxone to heroin users.Addiction. 1997 Sep;92(9):1195-9. Addiction. 1997. PMID: 9374020 Review.
-
Take-home naloxone to reduce heroin death.Addiction. 2005 Dec;100(12):1823-31. doi: 10.1111/j.1360-0443.2005.01259.x. Addiction. 2005. PMID: 16367983 Review.
Cited by
-
Organize and mobilize for implementation effectiveness to improve overdose education and naloxone distribution from syringe services programs: a randomized controlled trial.Implement Sci. 2024 Feb 28;19(1):22. doi: 10.1186/s13012-024-01354-y. Implement Sci. 2024. PMID: 38419058 Free PMC article. Clinical Trial.
-
Attitudes of Emergency Medical Service providers towards naloxone distribution programs.J Urban Health. 2005 Jun;82(2):296-302. doi: 10.1093/jurban/jti052. Epub 2005 May 25. J Urban Health. 2005. PMID: 15917504 Free PMC article.
-
Stakeholders' Perceptions of Factors Influencing the Use of Take-Home-Naloxone.Pharmacy (Basel). 2020 Dec 3;8(4):232. doi: 10.3390/pharmacy8040232. Pharmacy (Basel). 2020. PMID: 33287294 Free PMC article. Review.
-
Overdose Education and Naloxone for Patients Prescribed Opioids in Primary Care: A Qualitative Study of Primary Care Staff.J Gen Intern Med. 2015 Dec;30(12):1837-44. doi: 10.1007/s11606-015-3394-3. J Gen Intern Med. 2015. PMID: 26055224 Free PMC article.
-
Cocaine- and opiate-related fatal overdose in New York City, 1990-2000.BMC Public Health. 2007 Mar 9;7:31. doi: 10.1186/1471-2458-7-31. BMC Public Health. 2007. PMID: 17349051 Free PMC article.
References
-
- Strang J. Take-home naloxone: the next steps. Addiction. 1999;94:207–207. doi: 10.1046/j.1360-0443.1999.9421993.x. - DOI
-
- Sporer KA. Acute heroin overdose. Ann Intern Med. 1999;130:584–590. - PubMed
-
- Seal KH, Hammond JP, Ciccarone D, Downing M, Thawley R, Edlin B. Providing naloxone to IDUs can save lives. Paper presented at: Fourth National Harm Reduction Conference; December 1, 2002; Seattle, WA.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical